A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...

Scientists are racing to redesign how powerful painkillers work, aiming to keep the relief that opioids provide while ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...

Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain's support cells ...

According to Coherent Market Insights, the global Cell Reprogramming Market is estimated to be valued at USD 401.7 Mn in 2025 and is expected to reach USD 715.6 Mn by 2032, exhibiting a compound ...

A US Army Paratrooper assigned to 1st Brigade Combat Team, 82nd Airborne Division talks into a radio microphone during rotation 21-05 at the Joint Readiness Training Center on Fort Polk, La., March 7, ...

Aging can feel like an unstoppable force. Some researchers believe it may one day be slowed or even paused, thanks to an emerging technique known as cellular reprogramming. Curiosity has surrounded ...

A mechanism underlying neutrophil reprogramming in brain cancers has been uncovered, illuminating potential therapeutic targets to stop their pro-cancer effect. Tumor-infiltrating neutrophils are ...